Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12653945rdf:typepubmed:Citationlld:pubmed
pubmed-article:12653945lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C1556084lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C0006751lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C0242957lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C0069515lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C0021044lld:lifeskim
pubmed-article:12653945lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:12653945pubmed:issue4lld:pubmed
pubmed-article:12653945pubmed:dateCreated2003-3-25lld:pubmed
pubmed-article:12653945pubmed:abstractTextHER2 protein is over-expressed in 15-30% of breast carcinomas. Immunohistochemistry (IHC) is a common and inexpensive method able to specifically detect HER2 protein. However, lack of standardization of IHC has been considered responsible for discrepancies in HER2 status assessment performed by IHC and fluorescence in-situ hybridization (FISH). This prompted us to perform a multicentric IHC calibration test to achieve a maximum accuracy of HER2-IHC compared with HER2-FISH taken as the reference method.lld:pubmed
pubmed-article:12653945pubmed:languageenglld:pubmed
pubmed-article:12653945pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12653945pubmed:citationSubsetIMlld:pubmed
pubmed-article:12653945pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12653945pubmed:statusMEDLINElld:pubmed
pubmed-article:12653945pubmed:monthAprlld:pubmed
pubmed-article:12653945pubmed:issn0309-0167lld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:CouturierJJlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:RogerPPlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:RigaudCClld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:JacquemierJJlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:ArnouldLLlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:FicheMMlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:Le DoussalVVlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:TreilleuxIIlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:Penault-Llorc...lld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:MacGroganGGlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:Vincent-Salom...lld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:DenouxYYlld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:Mathoulin-Pél...lld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:MathieuM-CMClld:pubmed
pubmed-article:12653945pubmed:authorpubmed-author:VilainM-OMOlld:pubmed
pubmed-article:12653945pubmed:issnTypePrintlld:pubmed
pubmed-article:12653945pubmed:volume42lld:pubmed
pubmed-article:12653945pubmed:ownerNLMlld:pubmed
pubmed-article:12653945pubmed:authorsCompleteYlld:pubmed
pubmed-article:12653945pubmed:pagination337-47lld:pubmed
pubmed-article:12653945pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:meshHeadingpubmed-meshheading:12653945...lld:pubmed
pubmed-article:12653945pubmed:year2003lld:pubmed
pubmed-article:12653945pubmed:articleTitleCalibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study.lld:pubmed
pubmed-article:12653945pubmed:affiliationInstitut Curie, Paris, France. anne.salomon@curie.netlld:pubmed
pubmed-article:12653945pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12653945pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12653945pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12653945pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12653945lld:pubmed